FBRX
Forte Biosciences, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
Forte Biosciences, Inc.
Expected move
InputsNext report
Last report
—
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
Fund move
Fund move
No thesis.
Forte Biosciences, Inc.
77.01
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Federated InvestorsFederated Investors | $44.8M | 10.31% | +19.54% | |
| 2 | Orbimed AdvisorsOrbimed | $33.5M | 7.71% | +31.81% | |
| 3 | Fred Alger ManagementFred Alger | $30.6M | 7.04% | +13.01% | |
| 4 | Jupiter TopcoJupiter Topco | $29.2M | 6.72% | — | |
| 5 | BlackRockBlackRockindex-like | $26.0M | 5.98% | +1755.04% | |
| 6 | Affinity Asset AdvisorsAffinity Asset | $24.3M | 5.60% | +13.19% | |
| 7 | MPM Oncology Impact ManagementMPM Oncology Impact | $21.0M | 4.83% | −1.32% | |
| 8 | TCG Crossover ManagementTCG Crossover | $19.6M | 4.50% | new | |
| 9 | Vanguard Capital ManagementVanguardindex-like | $18.3M | 4.21% | +62.07% | |
| 10 | Woodline PartnersWoodline Partners | $15.1M | 3.48% | +114.69% | |
| 11 | Adage Capital Partners GPAdage Capital Partners GP | $14.9M | 3.42% | −26.32% | |
| 12 | Integral Health Asset ManagementIntegral Health | $14.3M | 3.30% | +350.00% | |
| 13 | Millennium ManagementMillennium | $13.9M | 3.20% | +93.86% | |
| 14 | Citadel AdvisorsCitadel | $11.6M | 2.68% | +134.57% | |
| 15 | FMRFMR | $10.7M | 2.46% | +47.59% | |
| 16 | Geode Capital ManagementGeodeindex-like | $10.1M | 2.31% | +277.29% | |
| 17 | Ameriprise FinancialAmeriprise Financial | $8.9M | 2.05% | +274.72% | |
| 18 | Cable Car CapitalCable Car Capital | $8.5M | 1.95% | 0.00% | |
| 19 | State StreetState Streetindex-like | $7.0M | 1.61% | +499.26% | |
| 20 | Candriam Luxembourg S.C.A.Candriam Luxembourg S.C.A. | $6.4M | 1.48% | +257.42% | |
| 21 | Boxer Capital ManagementBoxer | $5.8M | 1.34% | new | |
| 22 | Trails Edge Capital PartnersTrails Edge Capital Partners | $5.8M | 1.34% | new | |
| 23 | Sphera Funds ManagementSphera Funds | $5.3M | 1.22% | +34.98% | |
| 24 | Squadron Capital ManagementSquadron | $4.8M | 1.10% | new | |
| 25 | AWM InvestmentAWM Investment | $4.7M | 1.09% | +11.25% |
86 managers report $434.8M of Forte Biosciences on form 13F for the quarter ended Jun 30 '26. 18 of them hold 80% of it; Federated Investors is largest at 10.31%.
Expected move
No implied move.
No implied move.
No implied move.